Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

Andrew Bristol, PhD

Theriva Biologics

Disclosure(s): Theriva Biologics: Employee, Stocks/Bonds (Public Company)

Poster(s):

(P-104) Safety and tolerability of SYN-004 in allogeneic hematopoietic cell transplant (HCT) recipients receiving meropenem (MER) or piperacillin/tazobactam (P/T)

Monday, October 20, 2025
12:15 PM - 1:30 PM US ET